key: cord-0798533-dba25vgg
authors: Li, Kathy K.; Woo, Y. Mun; Stirrup, Oliver; Hughes, Joseph; Ho, Antonia; Filipe, Ana Da Silva; Johnson, Natasha; Smollett, Katherine; Mair, Daniel; Carmichael, Stephen; Tong, Lily; Nichols, Jenna; Aranday-Cortes, Elihu; Brunker, Kirstyn; Parr, Yasmin A.; Nomikou, Kyriaki; McDonald, Sarah E.; Niebel, Marc; Asamaphan, Patawee; Sreenu, Vattipally B; Robertson, David L.; Taggart, Aislynn; Jesudason, Natasha; Shah, Rajiv; Shepherd, James; Singer, Josh; Taylor, Alison H.M.; Cousland, Zoe; Price, Jonathan; Lees, Jennifer S.; Jones, Timothy P.W.; Lopez, Carlos Varon; MacLean, Alasdair; Starinskij, Igor; Gunson, Rory; Morris, Scott T.W.; Thomson, Peter C.; Geddes, Colin C.; Traynor, Jamie P.; Breuer, Judith; Thomson, Emma C.; Mark, Patrick B.
title: Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - a high risk community-hospital interface
date: 2021-04-22
journal: J Infect
DOI: 10.1016/j.jinf.2021.04.020
sha: 508798e8758ac8fab02c01c66a509e93b7e78080
doc_id: 798533
cord_uid: dba25vgg

OBJECTIVES: Patients requiring haemodialysis are at increased risk of serious illness with SARS-CoV-2 infection. To improve the understanding of transmission risks in six Scottish renal dialysis units, we utilised the rapid whole-genome sequencing data generated by the COG-UK consortium. METHODS: We combined geographical, temporal and genomic sequence data from the community and hospital to estimate the probability of infection originating from within the dialysis unit, the hospital or the community using Bayesian statistical modelling and compared these results to the details of epidemiological investigations. RESULTS: Of 671 patients, 60 (8.9%) became infected with SARS-CoV-2, of whom 16 (27%) died. Within-unit and community transmission were both evident and an instance of transmission from the wider hospital setting was also demonstrated. CONCLUSIONS: Near-real-time SARS-CoV-2 sequencing data can facilitate tailored infection prevention and control measures, which can be targeted at reducing risk in these settings.

The emergent SARS-CoV-2 virus which causes COVID-19 is associated with increased morbidity and mortality in older individuals and in those with chronic diseases. 1, 2 Chronic kidney disease and pre-existing conditions that may increase the risk of renal failure, such as cardiovascular disease, diabetes mellitus and hypertension, are significantly associated with an increased risk of death in COVID- 19 . 3, 4 Individuals requiring haemodialysis in hospital are also at increased risk of nosocomial infection due to prolonged outpatient dialysis (typically three times weekly for four hours per session) and to community infection due to regular travel on public or hospital transport, often with other patients. [5] [6] [7] The case fatality rate in dialysis patients has been reported as 20-30% compared with 1-2% in patients not requiring haemodialysis. [8] [9] [10] [11] Whole-genome pathogen sequencing has become increasingly accessible. Its utility in the context of evolving outbreaks has been demonstrated with Ebola, Zika and hospital outbreak investigations. [12] [13] [14] [15] The COVID-19 Genomics UK (COG-UK) Consortium, funded by the UK Department of Health and Social Care, UK Research and Innovation (UKRI) and the Wellcome Sanger Institute, was set up to enable realtime sequencing at a population level and to facilitate the investigation and management of hospital-associated infections, providing policymakers with information on introductions and transmission events. [16] [17] [18] We aimed to investigate the genetic epidemiology of COVID-19 infection from patients attending six Scottish renal dialysis unit(s) (RDU) using a Bayesian statistical analysis framework incorporating temporal, geographical and genetic sequence data. These results were evaluated alongside traditional epidemiological investigations. We further investigate the clinical impact of COVID-19 infection on haemodialysis patients and incorporate the information obtained using combined genetic and epidemiological data to inform future infection control strategies.

The Glasgow Renal and Transplant Unit based at the Queen Elizabeth University Initially, personal protective equipment (fluid-resistant surgical masks, eye protection, aprons and gloves) (PPE) was not recommended by UK and Scottish Governments for HCWs caring for patients, unless clinical index of suspicion was high for COVID-19 or for aerosol generating procedures. RDU1 instigated PPE for HCWs and surgical masks for patients whilst travelling to, from and during dialysis on 23 rd March in response to earlier infections. From 3 rd April 2020, the UK-recommendations changed to include any close patient contact. Surgical masks were also given to all patients, as per RDU1 and shared-patient transport discontinued. Until 5 th April HCWs were ineligible for SARS-CoV-2 testing unless hospitalised, being advised to self-isolate for 7 days in keeping with Scottish government policy.

Nasopharyngeal swabs in viral PCR solution (1:1 ratio of EasyMag Nuclisens Extraction Buffer (BioMerieux, France) and EMEM) were extracted and tested according to the availability of assays at the diagnostic laboratory. i Surplus RNA extract was collected for sequencing with ethical approval from the NHSGGC biorepository (16/WS/0207NHS).

Sequencing was performed on either the ONT MinION/GridION or the Illumina MiSeq platform, as previously described. 16 

Retrospective phylogenetic analysis of whole-genome sequences was performed as 

Comparisons were made between patients who lived and died following SARS-CoV-2 infection. At the time of analysis, no patients who were still alive were critically ill or requiring oxygen therapy. The mortality rates were calculated for patients requiring dialysis expressed as deaths per 1000 patient days were calculated over the three months 1 st March-31 st May 2020.

In total, 60 of 671 ( 

Residual 

In RDU3, three introductions and two separate transmission events were identified.

Although CVR375 and CVR1511 had indistinguishable sequences, this was shared with 161 other Scottish samples (Figure 2 , lineage UK5098 Figure 2 ) and appears likely to have been communityacquired on consideration of all available information. In lineage UK39, CVR937 was community-acquired while the related CVR1816 was probable within-unit transmission (p_RDU = 0.74).

In RDU4, two patients tested positive for SARS-CoV-2 but there was no linkage found on sequence analysis (Supplementary Table 1 Table 2 ). However, in RDU1, where the rate of infection was also high, there was tentative evidence of within-unit transmission; infections occurred over 12 days, the incubation period of the last case was coincident with both "lockdown" and enhanced PPE implementation.

During the first wave of the UK pandemic, we studied SARS-CoV-2 infections within 6 affected Scottish RDUs. Using a genomic epidemiology approach, we found that transmission of SARS-CoV-2 within RDUs was common, affecting 8·9% of dialysis patients with a very high associated mortality (27%) in keeping with other recent studies. 8 Scotland. 25 In order to capitalise on the utility of such knowledge in hospital-outbreak management, the results from the sequencing data need to be generated in a timely manner. 15, 17 However, the feasibility of implementing this rapid sequencing response in the National Health Service to date has been impeded by lack of expertise and equipment for both high-throughput whole-genome sequencing and for processing the data generated into a form interpretable by infection control and public health.

COG-UK has demonstrated that near real-time sequencing is achievable at scale. 17 We used this framework and a novel statistical algorithm to characterise transmission dynamics specifically in the haemodialysis cohort, a group both at higher risk of severe outcome as well as having numerous healthcare interactions.

A limitation of the study is the sequences available for analysis; accurate estimation of the likely source of infection depends on having sufficient sequences available from the community of affected patients and of cases from the hospital setting. Here, we obtained sequences from two-thirds of the lab-detected SARS-CoV-2 cases from RDU1-RDU5, and 44% for RDU6. We also compared data from the RDUs with 944 other cases in the community, 700 inpatients and 546 samples taken from patients presenting in emergency departments in the same health boards as provide care for dialysis patients. Additionally, COVID-19 is asymptomatic in up to 20% of patients, which may have reduced the number of infections captured. 26 Further, early in the pandemic, HCWs were ineligible for testing. Frequent, regular testing of all HCWs and all patients, regardless of symptoms is warranted. There is also mounting evidence that HCWs have a higher seroprevalence for SARS-CoV-2 antibodies than the general population, with a high proportion being asymptomatic. 27, 28 The low substitution rate of SARS-CoV-2 limits the granularity of outbreak analysis;

as demonstrated in this study, indistinguishable sequences may not be part of a transmission cluster if there is widespread circulation in the patients" home communities. To address this limitation, we employed the SRT, which combines sequence data with both temporal and geographic data to improve estimates of within-unit and within-hospital versus community transmission. Based on additional epidemiological evidence such as timing of haemodialysis sessions and hospital transport, the SRT correctly identified a high probability of within-unit transmission for RDU 2, 3, 5 and 6. Less definitive results for RDU1, not immediately apparent by phylogenetic investigation alone (due to the widespread presence the lineage within the community), affirm its potential as a rapid tool to aid outbreak investigations.

We confirm the findings of other published reports of SARS-CoV-2 in the haemodialysis cohort that cases are at risk of poor outcomes, with no specific at-risk group identified based on comorbid conditions. 9 The high mortality, dearth of therapeutics and likely poor response to vaccines, 29 Abbreviations BMIbody mass index, CVD -cardiovascular disease, COPDchronic obstructive pulmonary disease, PRD -primary renal disease, DN -diabetic nephropathy, GN -glomerulonephritis, AVF -arteriovenous fistula, AVGarteriovenous graft, RRT -renal replacement therapy, WCCwhite cell count, Hbhaemoglobin, Plts -platelets, Neutneutrophils, Lymphlymphocytes, NLRneutrophil to lymphocyte ratio, CXR -chest X-ray, CT -computed tomography of chest, CPAPcontinuous positive airway pressure Table 2 Number of patients treated at each RDU and proportion of patients infected with SARS-CoV-2 per RDU. Author contributions: Each named author has substantially contributed to conducting the underlying research and drafting this manuscript. Additionally, to the best of our knowledge, the named authors have no conflict of interest, financial or otherwise.

Ethical approval: Use of anonymised data was approved by the Local Privacy Advisory Group of NHS Greater Glasgow and Clyde "Safe Haven" on behalf of the West of Scotland Ethics Committee (approval GSH/20/RE/001). Surplus RNA extract was collected for sequencing with ethical approval from the NHSGGC biorepository (16/WS/0207NHS). 

A new coronavirus associated with human respiratory disease in China

A Novel Coronavirus from Patients with Pneumonia in China

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Minimizing the risk of COVID-19 among patients on dialysis

COVID-19 and dialysis: why we should be worried

Hemodialysis with Cohort Isolation to Prevent Secondary Transmission during a COVID-19 Outbreak in Korea

SARS-CoV-2 infection and early mortality of wait-listed and solid organ transplant recipients in England: a national cohort study

Presentation and Outcomes of Patients with ESKD and COVID-19

Clinical Features of Maintenance Hemodialysis Patients with

Novel Coronavirus-Infected Pneumonia in Wuhan, China

Rapid Whole-Genome Sequencing of

Mycobacterium tuberculosis Isolates Directly from Clinical Samples

Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples

Real-time, portable genome sequencing for Ebola surveillance

Use of Whole-Genome Sequencing in the Investigation of a Nosocomial Influenza Virus Outbreak

Genomic epidemiology of SARS-CoV-2 spread in Scotland highlights the role of European travel in COVID-19 emergence

Rapid implementation of SARS-CoV-2

sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study

Rapid SARS-CoV-2 wholegenome sequencing and analysis for informed public health decision-making in the Netherlands

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Fast and accurate long-read alignment with Burrows-Wheeler transform

An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar

Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data

The Incubation Period of Coronavirus Disease

COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy

COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry

Asymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis

Seroprevalence of SARS-COV-2 Antibodies in

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

Kinetics of antibody response to influenza vaccination in renal transplant recipients